A process is described for the purification of the person main small nuclear ribonucleoproteins (snRNPs) U1, U2, U5 and U4/U6 from HeLa cells. The salient characteristic of the tactic is the mixed utilization
A process is described for the purification of the person main small nuclear ribonucleoproteins (snRNPs) U1, U2, U5 and U4/U6 from HeLa cells. The salient characteristic of the tactic is the mixed utilization